[´Ý±â X]

Çùȸ¼Ò½Ä Çмú/ÇÐȸ º¸°ÇÁ¤Ã¥ Á¦¾à/À¯Åë ´Üü/º´¿ø ÀÇ·á±â±â ±â´É¼º½ÄÇ° ÇؿܼҽÄ
 
ȸ¿ø°¡ÀÔ ID/PWã±â
±â»ç°Ë»ö
2024-10-22,01:24(pm)





¼ºÀκ´ ¿øÀΰú ¿¹¹æ
¼ºÀκ´ ¿îµ¿¿ä¹ý
¼ºÀκ´°ú ½Ä»ýÈ°
¼ºÀκ´ Çѹæ¿ä¹ý
µ¥½ºÅ© Ä®·³
´ç´¢º´ Ŭ¸®´Ð
°íÇ÷¾Ð Ŭ¸®´Ð µî
¼ºÀκ´ ¹¯°í´äÇϱâ
¹Ú´Þȸ ¼öÇÊ ¸±·¹ÀÌ
À¯ÇüÁر³¼ö Æ÷·³
±èö¼ö¿øÀå Æ÷·³
¾È¿õ½Ä±³¼ö Æ÷·³

 

[µ¿Á¤]ÃÖÁ¤¿ì ±³¼ö,´ëÇѼ¼Æ÷º´¸®ÇÐȸ ´ë»ó ¼ö»ó
¼ºÀκ´´º½º (cdpnews@cdpnews.co.kr) 2017-09-12 ¿ÀÀü 10:43:00
ÃÖÁ¤¿ì °í·Á´ë ¾È»êº´¿ø º´¸®°ú ±³¼ö°¡ ´ëÇѼ¼Æ÷º´¸®ÇÐȸ°¡ ÁÖÃÖÇÑ 2017³â °¡À» Çмú´ëȸ¿¡¼­ ´ë»óÀ» ¼ö»óÇß´Ù. ¼ö»ó³í¹®Àº 2016³â Cancer Cytopathology¿¡ ½Ç¸° ¡®The Clinical Performance of Primary HPV Screening, Primary HPV Screening Plus Cytology Cotest and Cytology Alone at a Tertiary Care Hospital¡¯·Î ¼ö»óÀÇ ¿µ¿¹¸¦ ¾È°Ô µÈ ÃÖÁ¤¿ì ±³¼ö´Â ÀڱðæºÎ¾ÏÀ» Á¶±â¿¡ ¹ß°ßÇÏ´Â ½ºÅ©¸®´× °Ë»ç Áß ÀڱðæºÎ¾ÏÀÇ ÁÖ¿ä ¿øÀÎÀÎ HPV-DNA¿¡ ´ëÇÑ °Ë»ç¸¦ È°¿ëÇÑ ¹æ¹ýÀÌ ±âÁ¸ÀÇ ¼¼Æ÷Á᫐ °Ë»ç¸¸Å­ È¿À²ÀûÀÓÀ» ÃÖÃÊ·Î º´¿ø´ÜÀ§Á¶»ç¸¦ ÅëÇØ ¹àÇô³Â´Ù.
¡â ´ÙÀ½±Û : ±è°æ¹Î ±³¼ö,¹Ì±¹³»ºÐºñÇÐȸ ÀþÀº¿¬±¸ÀÚ»ó ¼ö»ó
¡ä ÀÌÀü±Û : ÇԾȱºº¸°Ç¼Ò ,Àç°¡¾Ï ȯÀÚ ¹× °¡Á· ¸ÂÃãÇü ÇÁ·Î±×·¥ ¿î¿µ


 



¼­¿ï½Ã µ¿ÀÛ±¸ µ¿ÀÛµ¿ 102 - 31 ¹øÁö ȯ3ºôµù 402È£ / ÀüÈ­: 02-594-5906~8 / FAX: 02-594-5901
Copyrights (c) 2004 cdpnews.co.kr All rights reserved